Does a prior diagnosis of Barrett's oesophagus influence risk of dying from oesophageal adenocarcinoma?

Gut

Volumn 64, Issue 1, 2015, Pages 5-6

  Whiteman, David C ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; HUMAN; LEAD TIME; NOTE; OVERALL SURVIVAL; PREVALENCE; ADENOCARCINOMA; BARRETT ESOPHAGUS; COMPLICATION; ESOPHAGEAL NEOPLASMS; FEMALE; MALE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE;

EID: 84919723789     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2014-307171     Document Type: Note

References (10)

1. Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol 2012; 23: 3155-62.
2. Thrift AP, Pandeya N, Whiteman DC. Current status and future perspectives on the etiology of esophageal adenocarcinoma. Front Oncol 2012; 2: 11.
3. Bhat S, McManus D, Coleman H, et al. Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population based study. Gut 2015; 64: 20-5.
4. Duffy SW, Nagtegaal ID, Wallis M, et al. Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival. Am J Epidemiol 2008; 168: 98-104.
5. Cooper GS, Kou TD, Chak A. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends. Am J Gastroenterol 2009; 104: 1356-62.
6. Corley DA, Levin TR, Habel LA, et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 2002; 122: 633-40.
7. Pinsky PF, Miller A, Kramer BS, et al. Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol 2007; 165: 874-81.
8. Rubenstein JH, Morgenstern H, Appelman H, et al. Prediction of Barrett's Esophagus Among Men. Am J Gastroenterol 2013; 108: 353-62.
9. Gordon LG, Mayne GC. Cost-effectiveness of Barrett's oesophagus screening and surveillance. Best Pract Res Clin Gastroenterol 2013; 27: 893-903.
10. Thrift AP, Kendall BJ, Pandeya N, et al. A clinical risk prediction model for Barrett esophagus. Cancer Prev Res (Phila) 2012; 5: 1115-23.